A retrospective review to assess the effect of prednisolone and azathioprine on usual interstitial pneumonia disease progression

M. J. Malik, B. E. Ladd, M. T. Henry (Leeds, United Kingdom)

Source: Annual Congress 2006 - Interstial lung diseases
Session: Interstial lung diseases
Session type: Poster Discussion
Number: 4763
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. J. Malik, B. E. Ladd, M. T. Henry (Leeds, United Kingdom). A retrospective review to assess the effect of prednisolone and azathioprine on usual interstitial pneumonia disease progression. Eur Respir J 2006; 28: Suppl. 50, 4763

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicentered open-label study
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

An observational study on effectiveness of azathioprine in treatment of interstitial lung disease secondary to connective tissue disease
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019


Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Infliximab therapy in patients with chronic progressive sarcoidosis – a retrospective follow-up study
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008

The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


A 12-week combination of clarithromycin and prednisone for the treatment of cryptogenic and radiation-induced organising pneumonia
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia
Source: Eur Respir J 2015; 45: 1624-1631
Year: 2015



Impact of steroid therapy on exacerbation of chronic obstructive pulmonary disease with community-onset pneumonia: a multicenter retrospective cohort study
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


A retrospective analysis of methotrexate therapy as a steroid sparing agent within a UK severe asthma clinic
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012



A case series on the use of steroids and mycophenolate mofetil in idiopathic and heritable pulmonary veno-occlusive disease: is there a role for immunosuppression?
Source: Eur Respir J, 57 (6) 2004354; 10.1183/13993003.04354-2020
Year: 2021



The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies
Source: Eur Respir J, 51 (6) 1800376; 10.1183/13993003.00376-2018
Year: 2018



Intravenous cyclophosphamide therapy for patients with interstitial pulmonary disease associated with collagen vascular disorders. A single-center experience
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. A retrospective study
Source: Annual Congress 2011 - New insights in the treatment of idiopathic pulmonary fibrosis
Year: 2011


Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study
Source: Eur Respir J, 55 (4) 1901983; 10.1183/13993003.01983-2019
Year: 2020



The course of COVID-19 in pulmonary sarcoidosis patients, receiving methotrexate
Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis
Year: 2021


Azathioprine and low-dose prednisone in chronic pulmonary sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

A retrospective analysis of our lung transplant cohort for the dichotomy within bronchiolitis obliterans syndrome and azithromycin therapy
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers
Year: 2018


The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 433s
Year: 2002

Impact of BAL lymphocytosis > 15% on the prognosis of chronic idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis: a retrospective nationwide study based on multidisciplinary discussion
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020